Wrong place at the wrong time: how retrograde trafficking drives cancer metastasis through receptor mislocalization

Abstract

Retrograde trafficking is a well-regulated, multi-component pathway that can result in endosomal trafficking to the trans-Golgi network, the perinuclear space, or the nucleus. Either clathrin or the retromer complex can travel with proteins endocytosed from the plasma membrane, guided by Rabs (including 5, 6, 7, 9, 22A), interacting with a host of sorting nexin proteins, and fusing with Golgi-specific anchors to allow transport of activated receptor tyrosine kinases to a potential end within the nucleus. Amplification in these constituents is common in cancer, leading to increased retrotranslocation and a reduction in degradation of receptor tyrosine kinases, an event highly associated with cancer metastasis. Here, we review the role of retrograde trafficking in altering transmembrane receptor localization and activity and the relationship to metastasis, focusing on all four members of the ErbB family, with comparison to other receptor tyrosine kinases including the insulin receptor and fibroblast growth factor receptor, as well as other transmembrane proteins dysregulated in metastasis. By examining how these receptors are being alternatively trafficked and the cancer-associated events resulting from this process, we hope to identify novel therapeutic targets.

Keywords

Retrograde trafficking / receptor tyrosine kinase / metastasis / nuclear receptor

References

[1] Zhang P,Deatherage C,DiMaio D.Cell-penetrating peptide mediates intracellular membrane passage of human papillomavirus L2 protein to trigger retrograde trafficking..Cell2018;174:1465-76 PMCID:PMC6128760

[2] Klinger SC,Nielsen MS.Retromer-mediated trafficking of transmembrane receptors and transporters..Membranes (Basel)2015;5:288-306 PMCID:PMC4584283

[3] Johannes L.Tracing the retrograde route in protein trafficking..Cell2008;135:1175-87

[4] Bonifacino JS.Retrograde transport from endosomes to the trans-Golgi network..Nat Rev Mol Cell Biol2006;7:568-79

[5] Lemmon MA.Cell signaling by receptor tyrosine kinases..Cell2010;141:1117-34 PMCID:PMC2914105

[6] Selyunin AS,Bartholomeusz G.Genome-wide siRNA screen identifies UNC50 as a regulator of Shiga toxin 2 trafficking..J Cell Biol2017;216:3249-62 PMCID:PMC5626549

[7] Matsudaira T,Taguchi T.Transport of the cholera toxin B-subunit from recycling endosomes to the Golgi requires clathrin and AP-1..J Cell Sci2015;128:3131-42

[8] Taubenschmid J,Jost M,Rillahan CD.A vital sugar code for ricin toxicity..Cell Res2017;27:1351-64 PMCID:PMC5674155

[9] Seaman MN.The retromer complex - endosomal protein recycling and beyond..J Cell Sci2012;125:4693-702 PMCID:PMC3517092

[10] Chia PZ,Lieu ZZ.Rab9-dependent retrograde transport and endosomal sorting of the endopeptidase furin..J Cell Sci2011;124:2401-13 PMCID:PMC3124371

[11] Zhang X.The role of APP and BACE1 trafficking in APP processing and amyloid-beta generation..Alzheimers Res Ther2013;5:46 PMCID:PMC3978418

[12] Makaraci P.Trans-Golgi network-bound cargo traffic..Eur J Cell Biol2018;97:137-49

[13] McKenzie JE,Zhou X,Taguchi T.Retromer guides STxB and CD8-M6PR from early to recycling endosomes, EHD1 guides STxB from recycling endosome to Golgi..Traffic2012;13:1140-59 PMCID:PMC3396774

[14] Purushothaman LK,Kuhlee A,Ungermann C.Retromer-driven membrane tubulation separates endosomal recycling from Rab7/Ypt7-dependent fusion..Mol Biol Cell2017;28:783-91 PMCID:PMC5349785

[15] Zaremba S.Assembly polypeptides from coated vesicles mediate reassembly of unique clathrin coats..J Cell Biol1983;97:1339-47 PMCID:PMC2112702

[16] Mellman I.Endocytosis and cancer..Cold Spring Harb Perspect Biol2013;5:a016949 PMCID:PMC3839607

[17] Lauvrak SU,Sandvig K.Efficient endosome-to-Golgi transport of Shiga toxin is dependent on dynamin and clathrin..J Cell Sci2004;117:2321-31

[18] Scott CC,Gruenberg J.Endosome maturation, transport and functions..Semin Cell Dev Biol2014;31:2-10

[19] Worby CA.Sorting out the cellular functions of sorting nexins..Nat Rev Mol Cell Biol2002;3:919-31

[20] De Camilli P,McPherson PS.Phosphoinositides as regulators in membrane traffic..Science1996;271:1533-9

[21] Kurten RC,Gill GN.Enhanced degradation of EGF receptors by a sorting nexin, SNX1..Science1996;272:1008-10

[22] Duclos CM,Carrier JC,Lavoie CL.Caspases play in traffic..Cell Death Dis2017;8:e2636 PMCID:PMC5386554

[23] Chin LS,Wei X,Li L.Hrs interacts with sorting nexin 1 and regulates degradation of epidermal growth factor receptor..J Biol Chem2001;276:7069-78

[24] Yang XZ,Zhang YJ,Xiang MQ.Rab1 in cell signaling, cancer and other diseases..Oncogene2016;35:5699-704 PMCID:PMC5396462

[25] Chia WJ.Emerging roles for Rab family GTPases in human cancer..Biochim Biophys Acta2009;1795:110-6

[26] Stenmark H.Rab GTPases as coordinators of vesicle traffic..Nat Rev Mol Cell Biol2009;10:513-25

[27] Cheng KW,Gray JW.Emerging role of RAB GTPases in cancer and human disease..Cancer Res2005;65:2516-9

[28] Short B,Schaletzky J,Barr FA.The Rab6 GTPase regulates recruitment of the dynactin complex to Golgi membrane..Curr Biol2002;12:1792-5

[29] Ceresa BP.Regulation of EGFR endocytic trafficking by rab proteins..Histol Histopathol2006;21:987-93

[30] Zhou Y,Li JH,Jiang JL.Rab22a enhances CD147 recycling and is required for lung cancer cell migration and invasion..Exp Cell Res2017;357:9-16

[31] Xiong F,Zhang F.MiR-204 inhibits the proliferation and invasion of renal cell carcinoma by inhibiting RAB22A expression..Oncol Rep2016;35:3000-8

[32] Wang T,Takano N,Luo W.Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis..Proc Natl Acad Sci U S A2014;111:E3234-42 PMCID:PMC4128139

[33] Zhang Y,Chen LL,Nephew KP.MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer..Oncotarget2014;5:12291-303 PMCID:PMC4323008

[34] Yang D,Wang K.miR-203 acts as a tumor suppressor gene in osteosarcoma by regulating RAB22A..PLoS One2015;10:e0132225 PMCID:PMC4575138

[35] Mallard F,Galli T,Saint-Pol A.Early/recycling endosomes-to-TGN transport involves two SNARE complexes and a Rab6 isoform..J Cell Biol2002;156:653-64 PMCID:PMC2174079

[36] Galvez T,Zerial M.SnapShot: mammalian rab proteins in endocytic trafficking..Cell2012;151:234-e2

[37] White J,Mallard F,Grill S.Rab6 coordinates a novel Golgi to ER retrograde transport pathway in live cells..J Cell Biol1999;147:743-60 PMCID:PMC2156170

[38] Personnic N,Finsel I.Subversion of retrograde trafficking by translocated pathogen effectors..Trends Microbiol2016;24:450-62

[39] Sotiriou C,McShane LM,Long PM.Breast cancer classification and prognosis based on gene expression profiles from a population-based study..Proc Natl Acad Sci U S A2003;100:10393-8 PMCID:PMC193572

[40] Scott KL,Liang MC,Anagnostou V.GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer..Nature2009;459:1085-90 PMCID:PMC2753613

[41] Maisel S,Schroeder J.Intravesicular epidermal growth factor receptor subject to retrograde trafficking drives epidermal growth factor-dependent migration..Oncotarget2017;9:6463-77 PMCID:PMC5814225

[42] Greenwood E,Ebertz D,Pandey R.Llgl1 prevents metaplastic survival driven by epidermal growth factor dependent migration..Oncotarget2016;7:60776-92 PMCID:PMC5308616

[43] Merlin J,de Beaucé S,Leteurtre E.Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells..Oncogene2011;30:2514-25

[44] Khan EM,Levy M,Ravid T.Epidermal growth factor receptor exposed to oxidative stress undergoes Src- and caveolin-1-dependent perinuclear trafficking..J Biol Chem2006;281:14486-93

[45] Chung BM,Clubb RJ,George M.Aberrant trafficking of NSCLC-associated EGFR mutants through the endocytic recycling pathway promotes interaction with Src..BMC Cell Biol2009;10:84 PMCID:PMC2790444

[46] Maher PA.Nuclear translocation of fibroblast growth factor (FGF) receptors in response to FGF-2..J Cell Biol1996;134:529-36 PMCID:PMC2120872

[47] Mitchell H,Pagano RE.Ligand-dependent and -independent transforming growth factor-beta receptor recycling regulated by clathrin-mediated endocytosis and Rab11..Mol Biol Cell2004;15:4166-78 PMCID:PMC515349

[48] Shewan AM,Martin S,Hong W.GLUT4 recycles via a trans-Golgi network (TGN) subdomain enriched in syntaxins 6 and 16 but not TGN38: involvement of an acidic targeting motif..Mol Biol Cell2003;14:973-86 PMCID:PMC151573

[49] Ralston E.GLUT4 in cultured skeletal myotubes is segregated from the transferrin receptor and stored in vesicles associated with TGN..J Cell Sci1996;109:2967-78

[50] Kanzaki M.Insulin receptor signals regulating GLUT4 translocation and actin dynamics..Endocr J2006;53:267-93

[51] Zhang H,Zeng X,Sachdev D.Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulation..Oncogene2010;29:2517-27 PMCID:PMC2861724

[52] Dearth RK,Kim HJ,Lawrence NA.Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2..Mol Cell Biol2006;26:9302-14 PMCID:PMC1698542

[53] Bryant DM,Stow JL.Regulation of endocytosis, nuclear translocation, and signaling of fibroblast growth factor receptor 1 by E-cadherin..Mol Biol Cell2005;16:14-23 PMCID:PMC539147

[54] Carpenter G.Nuclear localization and possible functions of receptor tyrosine kinases..Curr Opin Cell Biol2003;15:143-8

[55] Reilly JF.Importin beta-mediated nuclear import of fibroblast growth factor receptor: role in cell proliferation..J Cell Biol2001;152:1307-12 PMCID:PMC2199207

[56] Bitler BG,Schroeder JA.MUC1 regulates nuclear localization and function of the epidermal growth factor receptor..J Cell Sci2010;123:1716-23 PMCID:PMC2864713

[57] Ye T,Yin T,Li D.Inhibition of FGFR signaling by PD173074 improves antitumor immunity and impairs breast cancer metastasis..Breast Cancer Res Treat2014;143:435-46

[58] Coleman SJ,Ghallab M,Lemoine NR.Nuclear translocation of FGFR1 and FGF2 in pancreatic stellate cells facilitates pancreatic cancer cell invasion..EMBO Mol Med2014;6:467-81 PMCID:PMC3992074

[59] Yarden Y.Untangling the ErbB signaling network..Nat Rev Mol Cell Biol2001;2:127-37

[60] Hopkins CR,Beardmore JM.Receptor-mediated endocytosis of transferrin and epidermal growth factor receptors: a comparison of constitutive and ligand-induced uptake..J Cell Sci Supp1985;3:173-86

[61] Sorkin A.Endocytosis and intracellular trafficking of ErbBs..Exp Cell Res2008;314:3093-106 PMCID:PMC2605728

[62] Roepstorff K,Henriksen L,Lerdrup M.Differential effects of EGFR ligands on endocytic sorting of the receptor..Traffic2009;10:1115-27 PMCID:PMC2723868

[63] Willmarth NE,Dziubinski ML,Riese DJ2nd.Altered EGFR localization and degradation in human breast cancer cells with an amphiregulin/EGFR autocrine loop..Cell Signal2009;21:212-9 PMCID:PMC2632975

[64] Haigler HT,Cohen S.Rapid stimulation of pinocytosis in human carcinoma cells A-431 by epidermal growth factor..J Cell Biol1979;83:82-90 PMCID:PMC2110451

[65] Hanawa M,Dobashi Y,Kono K.EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus..Int J Cancer2006;118:1173-80

[66] Vieira AV,Schmid SL.Control of EGF receptor signaling by clathrin-mediated endocytosis..Science1996;274:2086-9

[67] Garay C,Lucarelli S,Pandey R.Epidermal growth factor-stimulated Akt phosphorylation requires clathrin or ErbB2 but not receptor endocytosis..Mol Biol Cell2015;26:3504-19 PMCID:PMC4591694

[68] Wang Y,Chen X.Endosomal signaling of epidermal growth factor receptor stimulates signal transduction pathways leading to cell survival..Mol Cell Biol2002;22:7279-90 PMCID:PMC139821

[69] Jorissen RN,Pouliot N,Ward CW.Epidermal growth factor receptor: mechanisms of activation and signalling..Exp Cell Res2003;284:31-53

[70] Sebastian S,Reshkin SJ,Bellizzi A.The complexity of targeting EGFR signalling in cancer: from expression to turnover..Biochim Biophys Acta2006;1766:120-39

[71] Wiley HS.Trafficking of the ErbB receptors and its influence on signaling..Exp Cell Res2003;284:78-88

[72] Nishimura Y,Ito S.EGF-stimulated AKT activation is mediated by EGFR recycling via an early endocytic pathway in a gefitinibresistant human lung cancer cell line..Int J Oncol2015;46:1721-9

[73] Cordenonsi M,Azzolin L,Rosato A.The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells..Cell2011;147:759-72

[74] Gan Y,Inge L,Balducci J.Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells..Oncogene2010;29:4947-58

[75] Bellacosa A,Godwin AK,Cheng JQ.Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas..Int J Cancer1995;64:280-5

[76] Sun M,Paciga JE,Yuan ZQ.AKT1/PKBα kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells..Am J Pathol2001;159:431-7 PMCID:PMC1850562

[77] Ringel MD,Saito J,Schuppert F.Overexpression and overactivation of Akt in thyroid carcinoma..Cancer Res2001;61:6105-11

[78] Sheng Q.The therapeutic potential of targeting the EGFR family in epithelial ovarian cancer..Br J Cancer2011;104:1241-5 PMCID:PMC3078592

[79] Meng Q,Fang J,Jiang BH.Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway..Cell Signal2006;18:2262-71

[80] Sainsbury JR,Needham GK,Harris AL.Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer..Lancet1987;1:1398-402

[81] Schiff BA,Jasser SA,Doan D.Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer..Clin Cancer Res2004;10:8594-602

[82] Hyatt DC.Cellular localization of the activated EGFR determines its effect on cell growth in MDA-MB-468 cells..Exp Cell Res2008;314:3415-25 PMCID:PMC2590673

[83] Wang YN,Lee HJ,Yamaguchi H.Membrane-bound trafficking regulates nuclear transport of integral epidermal growth factor receptor (EGFR) and ErbB-2..J Biol Chem2012;287:16869-79 PMCID:PMC3351284

[84] Wang YN,Yamaguchi H,Lee HH.COPI-mediated retrograde trafficking from the Golgi to the ER regulates EGFR nuclear transport..Biochem Biophys Res Commun2010;399:498-504 PMCID:PMC2935258

[85] Du Y,Hsu JL,Hsu MC.Syntaxin 6-mediated Golgi translocation plays an important role in nuclear functions of EGFR through microtubule-dependent trafficking..Oncogene2014;33:756-70 PMCID:PMC3874427

[86] Liao HJ.Role of the Sec61 translocon in EGF receptor trafficking to the nucleus and gene expression..Mol Biol Cell2007;18:1064-72 PMCID:PMC1805100

[87] Lo HW,Wu Y,Hsu SC.Nuclear-cytoplasmic transport of EGFR involves receptor endocytosis, importin beta1 and CRM1..J Cell Biochem2006;98:1570-83

[88] Hanada N,Day CP,Nakajima Y.Co-regulation of B-Myb expression by E2F1 and EGF receptor..Mol Carcinog2006;45:10-7

[89] Lo HW,Ali-Seyed M,Xia W.Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway..Cancer Cell2005;7:575-89

[90] Lo HW,Wei Y,Huang SF.Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer..Cancer Res2005;65:338-48

[91] Ortega J,Lee S,Gu L.Phosphorylation of PCNA by EGFR inhibits mismatch repair and promotes misincorporation during DNA synthesis..Proc Natl Acad Sci U S A2015;112:5667-72 PMCID:PMC4426468

[92] Saloura V,Zewde M,Kiyotani K.WHSC1L1-mediated EGFR mono-methylation enhances the cytoplasmic and nuclear oncogenic activity of EGFR in head and neck cancer..Sci Rep2017;7:40664 PMCID:PMC5244396

[93] Hadzisejdić I,Jonjić N,Grahovac B.Nuclear EGFR in ductal invasive breast cancer: correlation with cyclin-D1 and prognosis..Mod Pathol2010;23:392-403

[94] Hoshino M,Ono Y,Ichikawa K.Nuclear expression of phosphorylated EGFR is associated with poor prognosis of patients with esophageal squamous cell carcinoma..Pathobiology2007;74:15-21

[95] Lin SY,Xia W,Wen Y.Nuclear localization of EGF receptor and its potential new role as a transcription factor..Nat Cell Biol2001;3:802-8

[96] Pochampalli MR,Schroeder JA.Transforming growth factor alpha dependent cancer progression is modulated by Muc1..Cancer Res2007;67:6591-8

[97] Aggarwal P,Lin DI,Gladden AB.Nuclear accumulation of cyclin D1 during S phase inhibits Cul4-dependent Cdt1 proteolysis and triggers p53-dependent DNA rereplication..Genes Dev2007;21:2908-22 PMCID:PMC2049193

[98] Bertelsen V.The mysterious ways of ErbB2/HER2 trafficking..Membranes (Basel)2014;4:424-46 PMCID:PMC4194043

[99] Normanno N,Bianco C,Mancino M.Epidermal growth factor receptor (EGFR) signaling in cancer..Gene2006;366:2-16

[100] Slamon DJ,Wong SG,Ullrich A.Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene..Science1987;235:177-82

[101] Slamon DJ,Jones LA,Wong SG.Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer..Science1989;244:707-12

[102] Kennecke H,Woods R,Voduc D.Metastatic behavior of breast cancer subtypes..J Clin Oncol2010;28:3271-7

[103] Wang SC,Xia W,Lo HW.Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2..Cancer Cell2004;6:251-61

[104] Edwards J,Munro AF,Almushatat A.HER2 and COX2 expression in human prostate cancer..Eur J Cancer2004;40:50-5

[105] Thorat D,Behera R,Deshmukh S.Association of osteopontin and cyclooxygenase-2 expression with breast cancer subtypes and their use as potential biomarkers..Oncol Lett2013;6:1559-64 PMCID:PMC3834357

[106] Glynn SA,Ridnour LA,Dorsey TM.COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer..BMC Cancer2010;10:626 PMCID:PMC2993681

[107] Waterman H,Strano S,Yarden Y.The C-terminus of the kinase-defective neuregulin receptor ErbB-3 confers mitogenic superiority and dictates endocytic routing..EMBO J1999;18:3348-58 PMCID:PMC1171415

[108] Holbro T,Maurer F,Barbas CF3rd.The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation..Proc Natl Acad Sci U S A2003;100:8933-8 PMCID:PMC166416

[109] Alimandi M,Curia MC,Fedi P.Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas..Oncogene1995;10:1813-21

[110] Wallasch C,Niederfellner G,Issing W.Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3..EMBO J1995;14:4267-75 PMCID:PMC394510

[111] Kobayashi M,Shinohara-Kanda A,Fukui Y.Activation of ErbB3-PI3-kinase pathway is correlated with malignant phenotypes of adenocarcinomas..Oncogene2003;22:1294-301

[112] Roepstorff K,Grandal M,van Deurs B.Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer..Histochem Cell Biol2008;129:563-78 PMCID:PMC2323030

[113] Frazier NM,Gordan JD,Jura N.Overexpression-mediated activation of MET in the Golgi promotes HER3/ERBB3 phosphorylation..Oncogene2018;

[114] Andrique L,El Maassarani M,Vannier B.ErbB3(80 kDa), a nuclear variant of the ErbB3 receptor, binds to the cyclin D1 promoter to activate cell proliferation but is negatively controlled by p14ARF..Cell Signal2012;24:1074-85

[115] Koumakpayi IH,Le Page C,Gleave M.Expression and nuclear localization of ErbB3 in prostate cancer..Clin Cancer Res2006;12:2730-7

[116] Cheng CJ,Vakar-Lopez F,Tu SM.Bone microenvironment and androgen status modulate subcellular localization of ErbB3 in prostate cancer cells..Mol Cancer Res2007;5:675-84 PMCID:PMC2000833

[117] Yarden Y.The ERBB network: at last, cancer therapy meets systems biology..Nat Rev Cancer2012;12:553-63

[118] Schlessinger J.Nuclear signaling by receptor tyrosine kinases: the first robin of spring..Cell2006;127:45-8

[119] Mendoza-Naranjo A,Wai DH,Lazic N.ERBB4 confers metastatic capacity in Ewing sarcoma..EMBO Mol Med2013;5:1087-102 PMCID:PMC3721475

[120] Ljuslinder I,Isaksson-Mettävainio M,Henriksson R.ErbB 1-4 expression alterations in primary colorectal cancers and their corresponding metastases..Anticancer Res2009;29:1489-94

[121] Junttila TT,Lundin M,Tanner M.Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells..Cancer Res2005;65:1384-93

[122] Subtil A,Dautry-Varsat A.Rapid endocytosis of interleukin 2 receptors when clathrin-coated pit endocytosis is inhibited..J Cell Sci1994;107:3461-8

[123] Harding C,Stahl P.Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes..J Cell Biol1983;97:329-39 PMCID:PMC2112509

[124] Lamaze C,Baba T,Benmerah A.Interleukin 2 receptors and detergent-resistant membrane domains define a clathrin-independent endocytic pathway..Mol Cell2001;7:661-71

[125] Orlandi PA.Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains..J Cell Biol1998;141:905-15 PMCID:PMC2132770

[126] Barton DP,Wells AF,Roberts WS.Expression of interleukin-2 receptor alpha (IL-2R alpha) mRNA and protein in advanced epithelial ovarian cancer..Anticancer Res1994;14:761-72

[127] Tefferi A,Caramazza D,Lasho T.Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study..J Clin Oncol2011;29:1356-63

[128] Zwaagstra JC,O’Connor-McCourt MD.Predominant intracellular localization of the type I transforming growth factor-beta receptor and increased nuclear accumulation after growth arrest..Exp Cell Res2000;258:121-34

[129] Forrester E,Bierie B,Gorska AE.Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis..Cancer Res2005;65:2296-302

[130] Heldin CH,Moustakas A.Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition..Curr Opin Cell Biol2009;21:166-76

[131] Hayes S,Corvera S.TGF beta receptor internalization into EEA1-enriched early endosomes: role in signaling to Smad2..J Cell Biol2002;158:1239-49 PMCID:PMC2173232

[132] Di Guglielmo GM,Goodfellow AF.Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover..Nat Cell Biol2003;5:410-21

[133] Stechmann B,Gobbo E,Merer G.Inhibition of retrograde transport protects mice from lethal ricin challenge..Cell2010;141:231-42

[134] Luginbuehl V,Kovar K.Intracellular drug delivery: potential usefulness of engineered Shiga toxin subunit B for targeted cancer therapy..Biotechnol Adv2018;36:613-23

[135] Lo HW.Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival..Br J Cancer2006;94:184-8 PMCID:PMC2361115

[136] Giri DK,Li LY,Ling P.Endosomal transport of ErbB-2: mechanism for nuclear entry of the cell surface receptor..Mol Cell Biol2005;25:11005-18 PMCID:PMC1316946

[137] Dittmann K,Rodemann HP.Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity..Radiother Oncol2005;76:157-61

[138] Pilarczyk G,Gunkel M,Bestvater F.Localisation microscopy of breast epithelial ErbB-2 receptors and gap junctions: trafficking after gamma-irradiation, neuregulin-1beta, and trastuzumab application..Int J Mol Sci2017; PMCID:PMC5343897

[139] Hintersteiner M,Bednenko J,Knox AJ.Identification of a small molecule inhibitor of importin beta mediated nuclear import by confocal on-bead screening of tagged one-bead one-compound libraries..ACS Chem Biol2010;5:967-79 PMCID:PMC2956136

[140] Cordero JB,Lu Y,Slatopolsky E.1,25-Dihydroxyvitamin D down-regulates cell membrane growth- and nuclear growth-promoting signals by the epidermal growth factor receptor..J Biol Chem2002;277:38965-71